Back to Insights

Invesco S&P 500 Equal Weight ETF (RSP) ETF Analysis, July 2026

The Invesco S&P 500 Equal Weight ETF is a passively managed fund that holds all 500 companies in the S&P 500 but assigns each one the same portfolio weight, roughly 0.2 percent, regardless of its market capitalization. Unlike the S&P 500's traditional cap-weighting, which concentrates more heavily in the largest companies, RSP rebalances quarterly to maintain that equal weighting. As of July 24, 2026, RSP trades at $214.93 with $91.71 billion in assets under management, making it one of the largest equal-weight equity ETFs globally.

What Equal Weighting Means in Practice

Equal weighting sounds simple on the surface, but it creates a fundamentally different portfolio from the standard S&P 500. RSP holds 508 positions and resets them toward equal weight every quarter. That quarterly reset requires selling winners (positions that have risen above their target weight) and buying laggards (positions that have fallen below it), a practice that introduces both turnover and tax drag in taxable accounts. RSP is overweight industrials by about 7 percent, real estate by 4 percent, utilities by 3.3 percent, and materials by 3 percent, compared with the traditional S&P 500. Conversely, it is substantially underweight information technology by 18.4 percent and communication services by 6.5 percent.

This structural tilt matters enormously when mega-cap technology stocks lead market gains. As of April 30, 2026, RSP held roughly 3.59 billion dollars in cash, about 4.09 percent of net assets, a drag on returns in a rising market. Equal weighting also introduces higher volatility than cap-weighting. RSP experienced higher annualized volatility of 19.80 percent compared with 18.52 percent for SPY. That higher volatility did not translate to higher returns; RSP's risk-adjusted returns were weaker, producing a Sharpe ratio of 0.55 versus 0.59 for SPY.

Performance Over Multiple Time Horizons

RSP's recent performance context is important: the fund's results vary sharply depending on the measurement window. Over the trailing 5-year annualized period, RSP returned 7.2 percent according to MMD's data. Over the past decade, the picture is more challenging. From July 2016 to July 2026, RSP delivered 206.76 percent total return versus VOO's (Vanguard S&P 500 ETF) 314.79 percent. Over 5 years, RSP returned 53.18 percent while VOO returned 86 percent. That gap reflects both fees and the structural underweight to mega-cap growth leaders.

Yet 2026 has shown a near-term reversal. RSP is up roughly 12 percent year to date, running ahead of the cap-weighted SPDR S&P 500 ETF's roughly 10 percent gain. Over one year ending July 10, 2026, RSP gained 17.25 percent while VOO gained 22.04 percent, and the 1-year maximum drawdown of 14.7 percent aligns with the volatility profile noted above.

The Cost Question

The most pointed criticism of RSP centers on its fee structure relative to cap-weighted alternatives. RSP carries an expense ratio of 0.20 percent annually. By comparison, VOO charges 0.03 percent and iShares Core S&P 500 ETF (IVV) charges a similarly low fee. On a $10,000 position, that is a $20 annual fee versus $3, a gap that compounds over decades. The fee alone does not explain the performance gap, though; the larger drag comes from the quarterly rebalancing and cash position. Over ten years, a $10,000 stake in RSP on July 12, 2016 ended up significantly lower than an equivalent stake in VOO by July 10, 2026, and the fee sheet only explains a sliver of the gap. When rebalancing creates widespread turnover across 508 positions, the cumulative cost of transaction spreads and the opportunity cost of selling winners to buy laggards compounds.

Market Sentiment and the Yield Curve Factor

Market commentary on RSP has focused on a single macro variable: the shape of the yield curve. The 10-year minus 2-year Treasury spread sits at 0.40 percent, in only the 8th percentile of its 12-month range and well below the 0.54 percent average. A steepening curve, which historically arrives when the Fed cuts the front end, favors smaller-cap, cyclically sensitive, and financially levered names over mega-cap growth, and those are exactly the constituents RSP overweights relative to SPY. This is the bull case for RSP: if monetary policy shifts and the yield curve steepens, the very underweighting in mega-cap tech that has hurt RSP for years becomes an advantage. Conversely, if mega-cap dominance persists, RSP's structural drag remains a headwind.

Broader Context: An Active Bet Disguised as Passive

The deeper question is what exactly RSP represents. It holds the same 500 companies as the S&P 500 cap-weighted index, but RSP is an active bet on the average S&P 500 stock, one that requires paying a premium fee, tolerating a cash sleeve, absorbing quarterly turnover, and taking a structural underweight to the market's biggest winners. Over a long enough period, cap-weighting has dominated equal-weighting: over the 23-year period from April 2003 through July 2026, SPY generated an annualized return of 11.47 percent for a cumulative return of 1,145.58 percent, while RSP trailed at 11.25 percent annually for a cumulative return of 1,089.36 percent. That gap is material over decades.

RSP has merit if an investor holds a deliberate macro view that mega-cap tech is overvalued and a sustained leadership rotation is underway. Without that view, the vehicle introduces costs without compelling return justification. MMD can help you model the math: whether the annual fee difference, the rebalancing drag, and the cash position expense outweigh any diversification benefit you seek, and whether a specific tactical timing signal or valuation concern justifies the active tilt.

What to Watch

Monitor the yield curve: if the 10-year minus 2-year spread steepens materially above 0.50 percent, cyclical and mid-cap equity leadership could accelerate, potentially favoring RSP's underweight to mega-cap tech. Watch quarterly rebalance dates (RSP rebalances at the end of March, June, September, and December) for turnover-driven performance impacts and any changes in RSP's cash drag if market conditions shift. Track mega-cap earnings and guidance, particularly for the so-called Magnificent Seven technology stocks, to assess whether the valuation premium that drove 2023-2025 cap-weighted outperformance remains justified. Finally, observe whether new leadership candidates emerge among the smaller S&P 500 constituents where RSP is overweight; a sustained rotation away from mega-cap concentration would shift the risk-reward calculus substantially.

This analysis is educational and not investment advice. Use MMD's tools to stress-test how RSP fits your own portfolio goals and return expectations against lower-cost alternatives.


Disclaimer: This content is for educational and informational purposes only and does not constitute financial, investment, or tax advice. The information presented reflects the author's opinions and analysis at the time of writing and may not be suitable for your individual circumstances. Always consult with a qualified financial advisor before making investment decisions. Past performance is not indicative of future results. MinMaxDoc and its authors are not registered investment advisors.

{# Slug-keyed original-data widget + FAQ, rendered here in the template (NOT in post.content, which the evergreen refresh overwrites in place). #} {# Slug-keyed internal links to data-backed ETF comparison pages. Rendered in the TEMPLATE layer (not post.content) so the evergreen refresh can't clobber them. Only appears for mapped articles when the linked comparisons are live. #}

Get a free second opinion on your portfolio

See tax-aware buy & sell recommendations tailored to your actual holdings — completely free, no credit card required.

Get my free second opinion →

MinMaxDoc Weekly

Market insights & portfolio education in your inbox. No account needed.

Double opt-in — we'll email you to confirm. Unsubscribe anytime. We never share your address.

MinMaxDoc Editorial Team
Published by

How we research, write, and review the MinMaxDoc Insights you read.

Comments (0)

No comments yet. Be the first to comment!

Join the conversation

You need to be logged in to comment on this article.

Log in to comment Create an account